Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
DAPI (Hydrochloride): DNA-Specific Fluorescent Probe
2026-09-19
DAPI (hydrochloride), also called 4',6-diamidino-2-phenylindole hydrochloride, is a minor groove DNA binding dye for chromosome staining, flow cytometry, and DNA visualization in histochemistry. Its strongest fluorescence comes from complexes with AT-rich double-stranded DNA, while live-cell use requires additional optimization because cellular permeability is limited.
-
Angiotensin II Workflows for Vascular Research
2026-09-18
Build controlled cell and animal models of GPCR signaling, oxidative stress, vascular remodeling, and aneurysm biology with Angiotensin II. This guide connects practical peptide handling to emerging evidence on mitochondrial NAD+ deficiency and collagen III turnover in aortic disease.
-
Pollen Interference in Hazardous Aerosol Fluorescence
2026-09-18
Zhang and colleagues show that pollen can distort excitation–emission matrix fluorescence classification of hazardous bioaerosol components. Their combination of spectral preprocessing, fast Fourier transform feature conversion, and random forest classification substantially improved recognition and offers a practical strategy for handling environmental interference.
-
DMH1: ALK2 Inhibitor Workflow for Organoids
2026-09-17
DMH1 offers a pathway-focused way to test BMP signaling in pancreatic ductal organoids while supporting mechanistic studies in NSCLC models. This guide translates the reference organoid strategy into practical dosing, readout, and troubleshooting decisions without overstating what has been directly demonstrated.
-
Genistein for Force–Autophagy Assay Design
2026-09-17
Genistein can help researchers separate kinase-dependent signaling from mechanically induced autophagy. This article develops a causality-focused assay framework grounded in cytoskeleton-dependent mechanotransduction, cancer biology, and reproducible experimental controls.
-
Vasopressin Analogues: Evidence, Methods, and Limits
2026-09-16
The reference review explains how vasopressin analogues convert one endogenous hormone into peptides with distinct antidiuretic, vasoconstrictive, hemostatic, and potentially antiviral profiles. Its main practical contribution is a structure–function framework for selecting analogues while recognizing the limits imposed by peptide stability, receptor distribution, delivery, and translational evidence.
-
Lypressin acetate: Research Workflows
2026-09-16
Lypressin acetate connects vasopressin-receptor signaling, vasoconstriction research, and exploratory antiviral assays in one well-characterized peptide workflow. This guide covers preparation, quantitative readouts, cross-domain controls, and troubleshooting for reproducible bench studies.
-
ML365 for Reliable TASK1 Assays
2026-09-15
A scenario-based guide to using ML365 (SKU B8483) in TASK1 channel studies, viability workflows, and neuroinflammation research. It explains assay compatibility, concentration selection, cross-platform potency, controls, and practical product-quality considerations.
-
N-Formimidoyl Thienamycin vs. New β-Lactams
2026-09-15
This 1982 comparative study evaluated N-formimidoyl thienamycin (MK0787) against a broad panel of resistant clinical isolates and several emerging β-lactam antibiotics. Its main contribution was to connect spectrum, bactericidal behavior, and β-lactamase independence across clinically important gram-negative and gram-positive groups, providing a useful benchmark for interpreting Cefoperazone and related agents.
-
Triptolide (PG490): Mechanism and Research Use
2026-09-14
Triptolide, also known as PG490, is a nanomolar bioactive compound used in cancer research, immune-signaling studies, and rheumatoid synovial fibroblast models. Its reported activity includes transcriptional suppression, IL-2 reduction, apoptosis induction, and inhibition of ovarian cancer cell invasion.
-
Olsalazine Sodium: Research Workflows
2026-09-14
Build reproducible inflammation, colorectal cancer, and xenobiotic-clearance assays with Olsalazine Sodium, a water-compatible mesalamine dimer. This guide connects LTB4 chemotaxis inhibition and tumor biology with a reference workflow for measuring mosquito xenobiotic clearance and transporter expression.
-
Substance P: Assay Design Beyond the Receptor
2026-09-13
Explore Substance P as a tachykinin neuropeptide through an assay-design lens spanning NK-1 signaling, peptide handling, and analytical controls. This guide also explains how fluorescence-data preprocessing research can improve decisions in pain transmission and neuroinflammation studies without overstating cross-domain evidence.
-
DMG-PEG2000-NH2 for LNP Bioconjugation
2026-09-12
DMG-PEG2000-NH2 combines a PEG2000 spacer, a DMG lipid anchor, and a reactive amine for practical liposome, LNP, and biomolecule-conjugation workflows. This guide connects formulation design with assay controls, troubleshooting, and translational interpretation without overstating evidence from unrelated disease models.
-
DMXAA (Vadimezan): Reliable Assay Workflows
2026-09-11
Learn how DMXAA (Vadimezan), SKU A8233, can be integrated into reproducible viability, apoptosis, and angiogenesis workflows. This scenario-based guide connects its documented DTD and VEGFR2-related activities with practical decisions about solubility, controls, dose selection, and supplier reliability.
-
Gamithromycin PK/PD Targets in Piglet S. suis
2026-09-11
Wang et al. defined Streptococcus suis-specific pharmacodynamic targets for Gamithromycin in piglets and showed that serum exposure, rather than MIC alone, strongly influences apparent activity. The study links AUC24h/MIC to bacterial response, estimates a PK/PD cutoff, and provides a quantitative basis for dose-optimization studies without treating the simulated dose as a universal clinical recommendation.